AC-1204: Completed Phase III enrollment

Accera completed enrollment of >400 patients with mild to moderate AD in the

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE